GSK Related Earnings News
-
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
-
GlaxoSmithKline (GSK) Posts Flat Q1 EPS of 26.9p; Revs Ease
-
GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease
-
GlaxoSmithKline (GSK) Q3 EPS Falls to 22.6p; Revs Lower Y/Y
-
UBS Maintains a 'Buy' in Auxilium Pharmaceuticals (AUXL); Positive Physician Survey Results
-
Are Obesity Pills Hammering the Nail in Weight Watchers' (WTW) Coffin? Maybe Not...
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
Needham & Company Maintains a 'Buy' on Gilead Sciences (GILD); Q2 Preview; Quad Pill Update
-
Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK
-
Amicus Therapeutics, Inc. (FOLD) Tops Q1 EPS by 1c; Guides In-line
-
GlaxoSmithKline (GSK) MIsses Q1 EPS Views on Lighter Revs
-
GlaxoSmithKline (GSK) Reports Mixed Q4 Results
-
Highlights From JNJ's Q4 Conference Call: International and Consumer Brands Up, Procedures Down
-
GlaxoSmithKline (GSK) Posts Mixed Q1 Results
-
Quest Diagnostics (DGX) To Buyback 15.4M Common from Glaxo (GSK) Affilate; Increases FY11 Outlook
-
GlaxoSmithKline (GSK) Reports Q3 Adj-EPS of 28.2P, Sales £6.81B
-
GlaxoSmithKline (GSK) Reports Q4 Adj-EPS of 34.4P, vs. Consensus of 33.5P
-
Highlights From PFE's Q4 Conference Call: Wyeth Integration Going Well; Issues Guidance Through 2012
-
Highlights From GILD's Q4 Conference Call: Q4 Crossed $2 Billion Mark for First Time in Company History
-
GlaxoSmithKline (GSK) Reports Q3 Adj-EPS of 28.5p
-
Highlights From AMGN's Q2 Conference Call: Positive on Glaxo (GSK) Collaboration - Raises FY Guidance
-
Highlights From Pfizer's (PFE) Q1 Conference Call: Financing For Wyeth Acquisition In Order; Reaffirms Outlook
-
Glaxosmithkline plc (GSK) Shares Trading Higher on Earnings Report and Increased Stock Buyback
-
GlaxoSmithKline (GSK) CEO: Reiterates '07 Guidance Despite Avandia - DJ
-
GlaxoSmithKline (GSK) and EPIX Pharmaceuticals (EPIX) Announce Strategic and Development Collaboration
-
UPDATE - Cytokinetics (CYTK) Amends Collaboration with GlaxoSmithKline (GSK), Revises FY06 Guidance
-
Human Genome Sciences (HGSI) Updates Recent Collaborations, Contracts and Financial Outlook
-
Earnings Due Out After The Close Today And Before The Open Tomorrow
-
NPS Pharmaceuticals (NPSP) Tops Q1 EPS by 20c
Back to GSK Stock Lookup
